ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $172,100,000 | -2.0% | 1,000,000 | -28.6% | 3.85% | +8.0% |
| Q2 2021 | $175,686,000 | -7.5% | 1,400,000 | 0.0% | 3.57% | +6.3% |
| Q1 2021 | $189,854,000 | +6.0% | 1,400,000 | 0.0% | 3.36% | -12.7% |
| Q4 2020 | $179,116,000 | +13.7% | 1,400,000 | 0.0% | 3.84% | +0.5% |
| Q3 2020 | $157,542,000 | +18.1% | 1,400,000 | 0.0% | 3.82% | +2.5% |
| Q2 2020 | $133,378,000 | -1.1% | 1,400,000 | -6.7% | 3.73% | -34.5% |
| Q1 2020 | $134,805,000 | +111.9% | 1,500,000 | +25.0% | 5.70% | +131.8% |
| Q4 2019 | $63,624,000 | +7.4% | 1,200,000 | -20.0% | 2.46% | +3.5% |
| Q3 2019 | $59,265,000 | -3.8% | 1,500,000 | 0.0% | 2.38% | -4.7% |
| Q2 2019 | $61,620,000 | -28.5% | 1,500,000 | -18.9% | 2.49% | -29.2% |
| Q1 2019 | $86,155,000 | +58.3% | 1,850,000 | +48.0% | 3.52% | +74.4% |
| Q4 2018 | $54,438,000 | -4.9% | 1,250,000 | +25.0% | 2.02% | +35.5% |
| Q3 2018 | $57,230,000 | +7.2% | 1,000,000 | -9.1% | 1.49% | +31.3% |
| Q2 2018 | $53,372,000 | +60.6% | 1,100,000 | +29.4% | 1.13% | +172.6% |
| Q1 2018 | $33,235,000 | +4.4% | 850,000 | +13.3% | 0.42% | -13.3% |
| Q4 2017 | $31,830,000 | +21.8% | 750,000 | +7.1% | 0.48% | +6.7% |
| Q3 2017 | $26,124,000 | +22.8% | 700,000 | 0.0% | 0.45% | +21.0% |
| Q2 2017 | $21,273,000 | +7.2% | 700,000 | -6.7% | 0.37% | -15.6% |
| Q1 2017 | $19,853,000 | +418.6% | 750,000 | +400.0% | 0.44% | +418.8% |
| Q4 2016 | $3,828,000 | -39.6% | 150,000 | -14.3% | 0.08% | -32.0% |
| Q3 2016 | $6,333,000 | +86.4% | 175,000 | +75.0% | 0.12% | +78.6% |
| Q2 2016 | $3,398,000 | – | 100,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |